Cargando…
Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia
BACKGROUND: Congenital pseudoarthrosis of the tibia (CPT) is one of the most difficult conditions to treat. METHODS: Five girls and 3 boys with CPT were treated by vascularized fibular grafting (VFG). The average age at VFG was 7.0 years (range: 1.9–11.5 years) with an average follow-up term of 11.7...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2278130/ https://www.ncbi.nlm.nih.gov/pubmed/18325091 http://dx.doi.org/10.1186/1749-799X-3-13 |
_version_ | 1782152041236267008 |
---|---|
author | Sakamoto, Akio Yoshida, Tatsuya Uchida, Yoshio Kojima, Tetsuo Kubota, Hideaki Iwamoto, Yukihide |
author_facet | Sakamoto, Akio Yoshida, Tatsuya Uchida, Yoshio Kojima, Tetsuo Kubota, Hideaki Iwamoto, Yukihide |
author_sort | Sakamoto, Akio |
collection | PubMed |
description | BACKGROUND: Congenital pseudoarthrosis of the tibia (CPT) is one of the most difficult conditions to treat. METHODS: Five girls and 3 boys with CPT were treated by vascularized fibular grafting (VFG). The average age at VFG was 7.0 years (range: 1.9–11.5 years) with an average follow-up term of 11.7 years (range: 4.9–19.6 years). Five of the children had undergone multiple operations before VFG, while the other 3 had no such history. RESULTS: Bone consolidation was obtained in all cases after an average term of 6.6 months (range: 4–10 months); this was with the first VFG in 7 cases but with the second VFG in 1 case. Complication of stress fracture and ankle pain occurred in 1 and 3 cases, respectively, only in cases undergoing multiple operations. Leg-length discrepancy was more prominent in the patients with multiple previous operations (mean: 7.5 cm), than in the cases with no prior surgery (mean: 0.7 cm). CONCLUSION: The long-term results of VFG for CPT were excellent, especially in the cases, with no prior surgery. VFG should be considered as a primary treatment option for CPT. |
format | Text |
id | pubmed-2278130 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-22781302008-04-02 Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia Sakamoto, Akio Yoshida, Tatsuya Uchida, Yoshio Kojima, Tetsuo Kubota, Hideaki Iwamoto, Yukihide J Orthop Surg Research Article BACKGROUND: Congenital pseudoarthrosis of the tibia (CPT) is one of the most difficult conditions to treat. METHODS: Five girls and 3 boys with CPT were treated by vascularized fibular grafting (VFG). The average age at VFG was 7.0 years (range: 1.9–11.5 years) with an average follow-up term of 11.7 years (range: 4.9–19.6 years). Five of the children had undergone multiple operations before VFG, while the other 3 had no such history. RESULTS: Bone consolidation was obtained in all cases after an average term of 6.6 months (range: 4–10 months); this was with the first VFG in 7 cases but with the second VFG in 1 case. Complication of stress fracture and ankle pain occurred in 1 and 3 cases, respectively, only in cases undergoing multiple operations. Leg-length discrepancy was more prominent in the patients with multiple previous operations (mean: 7.5 cm), than in the cases with no prior surgery (mean: 0.7 cm). CONCLUSION: The long-term results of VFG for CPT were excellent, especially in the cases, with no prior surgery. VFG should be considered as a primary treatment option for CPT. BioMed Central 2008-03-06 /pmc/articles/PMC2278130/ /pubmed/18325091 http://dx.doi.org/10.1186/1749-799X-3-13 Text en Copyright © 2008 Sakamoto et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Sakamoto, Akio Yoshida, Tatsuya Uchida, Yoshio Kojima, Tetsuo Kubota, Hideaki Iwamoto, Yukihide Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia |
title | Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia |
title_full | Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia |
title_fullStr | Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia |
title_full_unstemmed | Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia |
title_short | Long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia |
title_sort | long-term follow-up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2278130/ https://www.ncbi.nlm.nih.gov/pubmed/18325091 http://dx.doi.org/10.1186/1749-799X-3-13 |
work_keys_str_mv | AT sakamotoakio longtermfollowupontheuseofvascularizedfibulargraftforthetreatmentofcongenitalpseudarthrosisofthetibia AT yoshidatatsuya longtermfollowupontheuseofvascularizedfibulargraftforthetreatmentofcongenitalpseudarthrosisofthetibia AT uchidayoshio longtermfollowupontheuseofvascularizedfibulargraftforthetreatmentofcongenitalpseudarthrosisofthetibia AT kojimatetsuo longtermfollowupontheuseofvascularizedfibulargraftforthetreatmentofcongenitalpseudarthrosisofthetibia AT kubotahideaki longtermfollowupontheuseofvascularizedfibulargraftforthetreatmentofcongenitalpseudarthrosisofthetibia AT iwamotoyukihide longtermfollowupontheuseofvascularizedfibulargraftforthetreatmentofcongenitalpseudarthrosisofthetibia |